ORIGENE TECHNOLOGIES INC.

History

Year	Detail
1996	In 1996, OriGene Technologies was founded as a research tool company focused on creating a sizeable commercial collection of full-length human cDNAs, which supply tools for gene-based research.
2010	OriGene developed mouse monoclonal antibodies against full-length human proteins as immunogens. These antibodies provide higher sensitivity and specificity than peptide-derived antibodies.
2011	The company developed a high-density protein microarray chip for antibody evaluation at the proteome-wide level. This chip is spotted with over 17,000 overexpression proteins in duplicate on a single nitrocellulose-coated glass slide and various positive and negative controls.
2012	OriGene developed a high-density protein microarray for antibody specificity testing, with the goal of solving antibody non-specificity and cross-reactivity issues in diagnostic assays.
2013	The company acquired SDIX, a life-sciences technology provider, for $16 million to develop a comprehensive collection of monoclonal antibodies for key applications in research and diagnostics.
2015	The company acquired Acris Antibodies GmbH, a Herford, Germany, and San Diego-based provider of antibodies and other life science-related products, to leverage its global reach to bring Acris products to a more extensive customer base.